<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIMS: While patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> develop oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> more frequently than the general population, it has controversially been suggested that <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e> (GORD) itself is a more important determinant of risk </plain></SENT>
<SENT sid="1" pm="."><plain>In order to assess the validity of this suggestion, we examined the risk of <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> in patients with Barrett's and with GORD compared with the general population in a community based cohort study </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Cohorts of patients with Barrett's (n = 1677), <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> (n = 6392), and simple reflux (n = 6328), and a reference cohort (n = 13416) were selected from the General Practice Research Database </plain></SENT>
<SENT sid="3" pm="."><plain>The last three cohorts were matched to the Barrett's cohort by general practitioner practice, age, and sex </plain></SENT>
<SENT sid="4" pm="."><plain>Cox's regression analysis was used to calculate relative risks for <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Standardised incidence ratio methodology was used to estimate the relative risks for oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: A total of 137 oesophageal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were identified, of which 94 prevalent cases were excluded </plain></SENT>
<SENT sid="7" pm="."><plain>The hazard ratios for <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> were 10.6 (5.1-22.0), 2.2 (0.9-5.2), and 1.7 (0.7-4.5) in the Barrett's, <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e>, and reflux cohorts compared with the reference cohort, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The corresponding relative risks for oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> were 29.8 (9.6-106), 4.5 (1.04-19.6), and 3.1 (0.6-14.2) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> increases the risk of <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> approximately 10 times and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> approximately 30 times compared with the general population </plain></SENT>
<SENT sid="10" pm="."><plain>There is only a modestly increased risk of <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> in patients with reflux who have no record of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Our findings therefore do not support the suggestion that <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> itself predisposes to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>